Question follow-through · 17846

Life Sciences: Investment

To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's joint press release entitled UK life sciences attracts £3bn investment, creating jobs and faster patient treatments, published on 9 July 2026, what es

answeredDepartment for Science, Innovation and Technology

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department for Science, Innovation and Technology
Tabled
10 Jul 2026
Target answer date
14 Jul 2026
Answer
17 Jul 2026 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 10 Jul 2026

    Question tabled

    To ask the Secretary of State for Science, Innovation and Technology, with reference to her Department's joint press release entitled UK life sciences attracts £3bn investment, creating jobs and faster patient treatments, published on 9 July 2026, what es

  2. 14 Jul 2026

    Target answer date

    Date supplied by the official written-questions record.

  3. 17 Jul 2026

    Answer published

    The Department does not hold estimates for the number of jobs impact for all of the investments that make up the £3bn investment figure. However, we have assessed jobs created by the Life Sciences Innovative Manufacturing Fund. £87 million has been commit...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

No later same-department questions indexed.

This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.